Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus MeetingShafak Aluwini, Hans M. Westgeest, Stijn W. T. P. J. Heijmink et al.|European Urology Oncology|2019Cited by 47
Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus MeetingNiven Mehra, Margreet G.E.M. Ausems, Iris S. H. Kloots et al.|European Urology Open Science|2023Cited by 10
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)Pim Hendriks, Daphne D. D. Rietbergen, Arian R. van Erkel et al.|European Journal of Nuclear Medicine and Molecular Imaging|2024Cited by 8
Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)Pim Hendriks, Daphne D. D. Rietbergen, Arian R. van Erkel et al.|CardioVascular and Interventional Radiology|2022Cited by 4
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary ViewDaniela E. Oprea‐Lager, Niven Mehra, Tessa van Elst et al.|European Urology Open Science|2025Cited by 4